Like cyclin D1, c-MYC is an oncogene that regulates cell growth and cell proliferation at the G1 transition (102), and its amplification is associated with aggressive tumor behavior and poor outcome in patients with breast cancer (103). Here, CCND1 is linked to neoplasm.